Literature DB >> 26555552

Disease activity, obesity, functional disability, and depression in patients with rheumatoid arthritis : Impact on lipid status, glycoregulation, and risk for coronary heart disease.

P Ostojic1, D Bartolovic2.   

Abstract

OBJECTIVES: This study aims to estimate the impact of disease activity, obesity, functional disability, and depression on lipid status, glycoregulation, and risk for coronary heart disease (CHD) in patients with rheumatoid arthritis (RA). PATIENTS AND METHODS: A total of 36 patients with RA (30 women and 6 men, mean age 54.9 years, mean disease duration 7.9 years) were included in this study. We estimated the impact of age, body mass index, disease activity [assessed by DAS28 index and C-reactive protein (CRP) value], functional ability (estimated using the HAQ disability index), and depression [assessed using the Beck Depression Inventory (BDI)] on glycoregulation, lipid status, and risk for CHD in our patients. Glycoregulation was assessed by measuring insulin resistance, insulin, and glucose in blood. Lipids tested in blood included total cholesterol, HDL and LDL cholesterol, and triglycerides (TG). The 10-year risk for CHD was estimated using the Framingham risk score.
RESULTS: Of 36 patients, 11 (30.6 %) fulfilled the criteria for metabolic syndrome (MS). Ten of 11 patients (90.1 %) with MS have a 10-year risk for CHD greater than 10 % compared to only 3 of 25 patients (12 %) without MS (p = 0.0001). Patients with high disease activity had lower HDL values than patients with mild or moderate disease activity (1.4 vs. 1.7 mmol/l, p = 0.04). Significant correlations were observed between CRP level and insulinemia (ρ = 0.57, p = 0.003), as well as CRP level and the HOMA index (ρ = 0.59, p = 0.002). The body mass index (BMI) correlated significantly with total cholesterol (r = 0.46, p = 0.02), LDL (ρ = 0.41, p = 0.04), and TG (ρ = 0.65, p < 0.001) in blood. The HAQ-DI did not correlate either with parameters of glycoregulation or lipid status. There was a significant positive correlation between BDI and BMI (ρ = 0.60, p < 0.001). CONCULSION: Active RA is independently associated with decreased HDL cholesterol and increased insulin resistance. Obesity was found to be an independent risk factor for increased total cholesterol, LDL cholesterol, and TG. Depressed patients with RA tend to be overweight or obese and, therefore, have an unfavorable lipid profile.

Entities:  

Keywords:  Body mass index; Glucose metabolism; Lipids; Metabolic syndrome; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 26555552     DOI: 10.1007/s00393-015-1661-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  41 in total

1.  Obesity and the beta cell: lessons from leptin.

Authors:  Kevin D Niswender; Mark A Magnuson
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

2.  Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network.

Authors:  Ewa Kontny; Magdalena Plebanczyk; Barbara Lisowska; Malgorzata Olszewska; Pawel Maldyk; Wlodzimierz Maslinski
Journal:  Ann Rheum Dis       Date:  2011-10-11       Impact factor: 19.103

3.  Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox.

Authors:  Miguel A González-Gay; Carlos González-Juanatey
Journal:  Ann Rheum Dis       Date:  2014-07       Impact factor: 19.103

4.  Cardiovascular disease in Europe 2014: epidemiological update.

Authors:  Melanie Nichols; Nick Townsend; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2014-08-19       Impact factor: 29.983

5.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

Review 6.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman
Journal:  Arch Gen Psychiatry       Date:  2010-03

Review 7.  Hypertension in rheumatoid arthritis.

Authors:  V F Panoulas; G S Metsios; A V Pace; H John; G J Treharne; M J Banks; G D Kitas
Journal:  Rheumatology (Oxford)       Date:  2008-05-08       Impact factor: 7.580

8.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

9.  Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons.

Authors:  M C Corti; M E Salive; J M Guralnik
Journal:  J Clin Epidemiol       Date:  1996-05       Impact factor: 6.437

10.  Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

Authors:  Hyo-Jeong Kim; Takamasa Higashimori; So-Young Park; Hyejeong Choi; Jianying Dong; Yoon-Jung Kim; Hye-Lim Noh; You-Ree Cho; Gary Cline; Young-Bum Kim; Jason K Kim
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

View more
  3 in total

1.  The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE.

Authors:  S Chandrashekara; Sachin Vithalrao Dhote; K R Anupama
Journal:  Indian J Clin Biochem       Date:  2017-11-13

2.  Prevalence of Metabolic Syndrome in Patients With Rheumatoid Arthritis: An Updated Systematic Review and Meta-Analysis.

Authors:  Wei Cai; Xuemi Tang; Min Pang
Journal:  Front Med (Lausanne)       Date:  2022-04-08

3.  Development and validation of a nomogram to predict coronary heart disease in patients with rheumatoid arthritis in northern China.

Authors:  Tingting Wei; Bowen Yang; Haina Liu; Fangran Xin; Lingyu Fu
Journal:  Aging (Albany NY)       Date:  2020-02-29       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.